{
  "@context": "aku-v2",
  "@type": "procedure",
  "@id": "wsmg:health-sciences/medicine/nephrology/neph-046",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:53:50.000Z",
    "modified": "2026-01-13T14:32:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/nephrology",
    "subdomain": "diagnostic_procedures",
    "type": "procedure",
    "difficulty": "intermediate",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Proteinuria Evaluation",
    "summary": "Proteinuria is a key marker of kidney disease requiring systematic evaluation to quantify, categorize, and identify the underlying cause. The workup distinguishes albuminuria from other protein types, uses spot urine protein-to-creatinine ratio (UPCR) or albumin-to-creatinine ratio (UACR) for quantification, and guides further investigation based on the pattern and severity.",
    "key_points": [
      "Spot UACR or UPCR correlates well with 24-hour collection; first morning void is most accurate",
      "Albuminuria ≥30 mg/g (A2) indicates kidney damage even with normal GFR",
      "Nephrotic-range proteinuria: >3.5 g/day or UPCR >3500 mg/g",
      "Always rule out orthostatic proteinuria in young patients (<30 years)",
      "Proteinuria reduction is a therapeutic target to slow CKD progression",
      "SPEP/UPEP if light chain disease suspected (overflow proteinuria)"
    ],
    "statement": "Proteinuria evaluation is a structured diagnostic approach to detect, quantify, and characterize urinary protein excretion, distinguishing albuminuria from overflow and tubular proteinuria to guide diagnosis and management of kidney disease.",
    "explanation": {
      "intuition": "The glomerular filtration barrier normally blocks proteins by size and charge. Proteinuria indicates this barrier is damaged (glomerular leak), tubules failed to reabsorb filtered proteins (tubular), or excess proteins overwhelmed normal reabsorption (overflow). Each pattern has different causes and implications.",
      "key_insight": "Albuminuria (measured by UACR) is the most clinically relevant because it specifically reflects glomerular damage and is an independent cardiovascular risk factor. The A1/A2/A3 staging integrates with GFR (G1-5) to risk-stratify CKD prognosis.",
      "technical_details": "Normal albumin excretion is <30 mg/day. The dipstick detects albumin ≥300 mg/L but misses microalbuminuria. UACR on spot urine (preferably first AM void) correlates r=0.97 with 24h collection. Sulfosalicylic acid precipitates all proteins including light chains."
    },
    "definitions_glossary": {
      "proteinuria": "Abnormal excretion of protein in urine; >150 mg/day total protein",
      "albuminuria": "Abnormal excretion of albumin; marker of glomerular damage",
      "microalbuminuria": "Albumin 30-300 mg/day; now termed moderately increased albuminuria (A2)",
      "macroalbuminuria": "Albumin >300 mg/day; severely increased albuminuria (A3)",
      "nephrotic_range_proteinuria": "Protein excretion >3.5 g/day or UPCR >3500 mg/g",
      "UACR": "Urine albumin-to-creatinine ratio; expressed as mg/g",
      "UPCR": "Urine protein-to-creatinine ratio; estimates 24h protein in g/day",
      "orthostatic_proteinuria": "Benign proteinuria present only when upright; absent in first AM void",
      "overflow_proteinuria": "Excess filtered protein (e.g., light chains) exceeding tubular reabsorption",
      "tubular_proteinuria": "Low-molecular-weight proteins from impaired tubular reabsorption",
      "glomerular_proteinuria": "Albumin-predominant from damaged glomerular filtration barrier",
      "selectivity_index": "IgG:albumin clearance ratio; <0.1 suggests selective (minimal change disease)",
      "SPEP": "Serum protein electrophoresis; detects monoclonal proteins"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Protein appears in urine when glomerular barrier fails, tubular reabsorption is impaired, or filtered load exceeds capacity",
      "types": {
        "glomerular": {
          "mechanism": "Damage to glomerular basement membrane or podocytes increases permeability",
          "protein_type": "Primarily albumin (67 kDa); selectivity indicates minimal change vs FSGS",
          "examples": ["Diabetic nephropathy", "Membranous nephropathy", "Minimal change disease", "FSGS"]
        },
        "tubular": {
          "mechanism": "Impaired proximal tubule reabsorption of filtered low-molecular-weight proteins",
          "protein_type": "Beta-2 microglobulin, retinol-binding protein, alpha-1 microglobulin",
          "examples": ["Fanconi syndrome", "Acute tubular necrosis", "Drug-induced tubulopathy"]
        },
        "overflow": {
          "mechanism": "Excessive production of small proteins overwhelms normal tubular reabsorption",
          "protein_type": "Light chains (Bence Jones), myoglobin, hemoglobin",
          "examples": ["Multiple myeloma", "Rhabdomyolysis", "Intravascular hemolysis"]
        },
        "functional": {
          "mechanism": "Transient proteinuria without structural kidney disease",
          "examples": ["Fever", "Exercise", "Heart failure", "Orthostatic proteinuria"]
        }
      }
    },
    "diagnostic_criteria": {
      "KDIGO_albuminuria_staging": {
        "A1_normal": "<30 mg/g",
        "A2_moderately_increased": "30-300 mg/g (formerly microalbuminuria)",
        "A3_severely_increased": ">300 mg/g (formerly macroalbuminuria)"
      },
      "quantification_methods": {
        "dipstick": {
          "detects": "Albumin ≥300 mg/L (1+ = ~300, 2+ = ~1000 mg/L)",
          "limitations": "Misses microalbuminuria; false positives with concentrated/alkaline urine"
        },
        "spot_UACR": {
          "preferred_specimen": "First morning void",
          "interpretation": "mg albumin/g creatinine approximates mg/day"
        },
        "spot_UPCR": {
          "interpretation": "mg protein/g creatinine approximates g/day total protein"
        },
        "24h_collection": {
          "gold_standard": "Total protein and albumin quantification",
          "normal_values": "<150 mg protein/day, <30 mg albumin/day"
        }
      },
      "essential_workup": [
        "Spot UACR or UPCR on first morning void",
        "Repeat positive result to confirm persistent proteinuria",
        "Serum creatinine and eGFR",
        "Urinalysis with microscopy",
        "Split specimen (AM/PM) if orthostatic proteinuria suspected"
      ]
    },
    "differential_diagnosis": [
      "Diabetic kidney disease (most common cause of nephrotic syndrome in adults)",
      "Primary glomerulonephritis (minimal change, FSGS, membranous)",
      "Secondary glomerulonephritis (lupus, amyloid, infection-related)",
      "Multiple myeloma (overflow proteinuria - dipstick negative)",
      "Orthostatic proteinuria (benign in young patients)"
    ],
    "treatment_options": {
      "general_principles": [
        "Identify and treat underlying cause",
        "Target proteinuria reduction as key therapeutic goal",
        "Blood pressure control to <130/80 mmHg"
      ],
      "pharmacologic": {
        "ACE_inhibitors_ARBs": {
          "mechanism": "Reduce intraglomerular pressure and proteinuria",
          "indication": "First-line for proteinuric CKD and diabetic nephropathy",
          "target": "Reduce proteinuria by >50% or to <0.5 g/day"
        },
        "SGLT2_inhibitors": {
          "mechanism": "Reduce glomerular hyperfiltration independent of glucose",
          "indication": "CKD with proteinuria regardless of diabetes",
          "agents": ["Dapagliflozin", "Empagliflozin"]
        },
        "finerenone": {
          "mechanism": "Non-steroidal mineralocorticoid receptor antagonist",
          "indication": "Diabetic kidney disease with residual albuminuria on RAASi"
        }
      },
      "dietary": [
        "Sodium restriction <2 g/day enhances ACE-I/ARB effect",
        "Moderate protein intake 0.8 g/kg/day in CKD"
      ]
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Proteinuria Evaluation"
    },
    "altLabel": [
      {"@language": "en", "@value": "Albuminuria workup"},
      {"@language": "en", "@value": "Urine protein assessment"},
      {"@language": "en", "@value": "Protein in urine evaluation"}
    ],
    "definition": {
      "@language": "en",
      "@value": "A systematic diagnostic approach to detect, quantify, and characterize urinary protein excretion for diagnosis and management of kidney disease"
    },
    "notation": "neph-046",
    "scopeNote": {
      "@language": "en",
      "@value": "Covers evaluation of all types of proteinuria including albuminuria screening, quantification methods, and interpretation in CKD staging"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/diagnostic-procedures",
        "skos:prefLabel": "Nephrology Diagnostic Procedures"
      }
    ],
    "skos:narrower": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/microalbuminuria-screening",
        "skos:prefLabel": "Microalbuminuria Screening"
      }
    ],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-047",
        "skos:prefLabel": "Hematuria Evaluation"
      },
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-005",
        "skos:prefLabel": "Chronic Kidney Disease Staging"
      },
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-012",
        "skos:prefLabel": "Nephrotic Syndrome"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Proteinuria"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "29738008",
      "uri": "http://snomed.info/id/29738008",
      "description": "Proteinuria"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "R80.9",
      "uri": "http://hl7.org/fhir/sid/icd-10-cm/R80.9",
      "description": "Proteinuria, unspecified"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D011507",
      "uri": "http://id.nlm.nih.gov/mesh/D011507",
      "description": "Proteinuria"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Classify proteinuria by pathophysiology: glomerular, tubular, overflow, functional",
      "Use UACR and UPCR to quantify proteinuria from spot urine specimens",
      "Apply KDIGO albuminuria staging (A1-A3) to risk-stratify CKD",
      "Identify indications for nephrology referral based on proteinuria severity",
      "Select appropriate antiproteinuric therapy including ACE-I, ARB, and SGLT2i"
    ],
    "clinical_pearls": [
      "First morning void UACR is most accurate (avoids orthostatic contribution)",
      "Dipstick misses light chains - use sulfosalicylic acid or UPEP if myeloma suspected",
      "Nephrotic syndrome = proteinuria >3.5g/day + hypoalbuminemia + edema + hyperlipidemia",
      "A2 albuminuria (30-300 mg/g) is an independent CV risk factor even without GFR decline",
      "Target 50% proteinuria reduction - each doubling increases ESRD risk 3-fold"
    ],
    "board_yield": "HIGH",
    "estimated_time": "20min",
    "target_audience": [
      "medical_students",
      "internal_medicine_residents",
      "nephrology_fellows",
      "primary_care_physicians"
    ],
    "common_misconceptions": [
      "24-hour collection is always needed - spot UACR/UPCR is adequate for most purposes",
      "1+ dipstick protein is always significant - may be false positive with concentrated urine",
      "Orthostatic proteinuria needs treatment - it is benign and requires only reassurance"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/nephrology/neph-045",
      "skos:prefLabel": "Urinalysis Interpretation"
    }
  ],
  "related_concepts": [
    "urinalysis",
    "albuminuria",
    "chronic kidney disease staging",
    "nephrotic syndrome",
    "ACE inhibitors"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of CKD",
        "title": "Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group",
        "journal": "Kidney Int Suppl",
        "year": 2013,
        "volume": "3",
        "pages": "1-150",
        "doi": "10.1038/kisup.2012.73"
      }
    ],
    "confidence_rationale": "Based on KDIGO guidelines for CKD staging and proteinuria evaluation"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-13T14:32:00.000Z",
    "sources": [
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill, 2022.",
        "type": "textbook",
        "year": 2022,
        "isbn": "978-1264268504",
        "relevance": "Standard internal medicine reference"
      },
      {
        "source": "KDIGO 2012 CKD Guideline",
        "type": "clinical_guideline",
        "year": 2013,
        "relevance": "International evidence-based recommendations"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.94,
    "completeness": 0.95,
    "accuracy": 0.96,
    "clarity": 0.93,
    "clinical_relevance": 0.95,
    "last_assessed": "2026-01-13T14:32:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Proteinuria",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q847624"
}